MedTrace Logo

Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification

NCT02717702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2019-08-19

No results posted yet for this study

Summary

Acute Coronary Syndrome (ACS) is a serious heart condition that is a leading cause of death in America. Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization (placing a tube in the heart) for coronary angiogram (invasive mapping of the blood vessels of the heart). However, stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS.

Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test. The investigators seek to determine whether these blood tests can help to better identify patients with ACS. The study will also store any extra blood sample that may be left over for future use.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Alexander T Limkakeng, MD · Duke University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-10
Primary Completion
2018-05-07
Completion
2019-06-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02717702 on ClinicalTrials.gov